Age-related macular degeneration in Onitsha, Nigeria

Nigerian Journal of Clinical Practice

Volumn 14, Issue 3, 2011, Pages 327-331

  Nwosu, S N N ^a  

^a Guinness Eye Center   (Nigeria)

Author keywords

Age related macular degeneration; Age related maculopathy; Geographic atrophy; Low vision; Nigeria

Indexed keywords

AGE; AGED; ARTICLE; BLINDNESS; CATARACT; COMORBIDITY; DIABETES MELLITUS; FEMALE; GLAUCOMA; HUMAN; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NIGERIA; PATHOPHYSIOLOGY; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; TEACHING HOSPITAL; VISUAL ACUITY; VISUAL DISORDER;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLINDNESS; CATARACT; COMORBIDITY; DIABETES MELLITUS; FEMALE; GLAUCOMA; HOSPITALS, TEACHING; HUMANS; HYPERTENSION; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; NIGERIA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; VISION, LOW; VISUAL ACUITY;

EID: 84855246393     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.86778     Document Type: Article

References (26)

1. Cooper RL. Blindness registrations in Western Australia. Aust N Z J Ophthalmol 1990;18:421-6.
2. Tielsch JM. Vision problems in the US A report on blindness and vision impairment in adults age 40 and older. Schaumburg, Illinois: Prevent Blindness America; 1995. p. 1-20.
3. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia: The Blue Mountains Eye Study. Ophthalmology 1996;103:357-64. (Pubitemid 26085889)
4. Gregor Z, Joffe L. Senile macular degeneration in the black African. Br J Ophthalmol 1978;62:547-50. (Pubitemid 8383014)
5. Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch J. Racial differences in the prevalence of age-related macular degeneration: The Baltimore Eye Survey. Ophthalmology 1999;106:1049-55. (Pubitemid 30191504)
6. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruckshanks KJ. Age-related maculopathy in a multiracial United States population. Ophthalmology 1999;106:1056-65.
7. Schachat AP, Hyman L, Leske MC, Connell AM, Wu SY. Features of age-related macular degeneration in a black population: The Barbados Eye Study Group. Arch Ophthalmol 1995;113:728-35.
8. Ayanru JO. Environment, culture, and eye disease (Experience at Benin-City, Bendel State of Nigeria). Proc African Eye Seminar. Nairobi, Kenya: Merck, Sharp and Dohme Int; 1982. p. 42-63.
9. Abiose A. Retinal diseases in Nigeria: A preliminary report. Niger Med J 1978;6:180-3.
10. Nwosu SNN. Prevalence and pattern of retinal diseases at the Guinness Eye Hospital Onitsha, Nigeria. Ophthalmic Epidemiol 2000;7:41-8 (Pubitemid 30168945)
11. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration: The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74.
12. Nwosu SNN. Blindness and visual impairment in Anambra State, Nigeria. Trop Geogr Med 1994;46:346-9.
13. Nwosu SNN, Ezechukwu CC, Onyekwe LO. Eye diseases in preschool children in Onitsha, Nigeria. Trop J Med Res 1999;3:75-9.
14. Nwosu SNN. Domestic ocular and adnexal injuries in Nigerians. West Afr J Med 1995;14:33-5.
15. Nwosu SNN. Diabetic retinopathy in Nnewi, Nigeria. Niger J Ophthalmol 2000;8:7-10.
16. Omoti AE. Age-related macular degeneration in Benin-City Nigeria. CMS UNIBEN JMBR 2004;3:7-11.
17. Nwosu SNN, Onyekwe LO. Ocular problems of the elderly in Onitsha, Nigeria. Niger J Clin Pract 2002;5:123-6.
18. Age-related Eye Disease Study Research Group. Risk factors for incidence of advanced age-related macular degeneration in the Age-related Eye Disease Study (AREDS). AREDS Report No. 19 Ophthalmology 2005;112:533-9.
19. Klein R, Klein BE, Tomany SC, Cruckshanks KJ. The association of cardiovascular disease with long term incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 2003;110:636-43. (Pubitemid 36520056)
20. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease and age-related macular degeneration. Arch Ophthamol 2000;18:351-8. (Pubitemid 30152375)
21. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
22. Mitchell P, Wang JJ, Foran S, Wayne S. Five year incidence of age-related maculopathy lesions: The Blue Mountain Eye Study. Ophthalmology 2002;109:1092-7. (Pubitemid 34546916)
23. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Comparison of ranibizumab and verteporfin photodynamic therapy for neovascular age-related degeneration: 1-year results of the ANCHOR study. N Engl J Med 2006;355:1432-44.
24. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16. (Pubitemid 40051904)
25. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Eng J Med 2006;355:1419-31. (Pubitemid 44511557)
26. Age-related Eye Disease Study Research Group. A randomized placebocontrolled trial of high dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and vision loss. AREDS Report No.8. Arch Ophthalmol 2001;119:1417-36.